Download presentation
Presentation is loading. Please wait.
Published byOwen Watts Modified over 6 years ago
1
The Role of IVUS for Evaluation & Treatment Optimisation
The Venoplasty Programme The Venoplasty Programme, The Edinburgh Clinic, Scotland
3
CAROTID IVUS
4
CAROTID IVUS Irshad K, Reid D, Miller P et al J Endovasc Ther ; 8 :
5
Percutaneous Femoral Vein Access
6
Percutaneous Femoral Vein Access
7
IVUS
8
IVUS
9
Abnormal Valve
10
Abnormal Valve
11
Abnormal Valve
12
A Prospective Study of Clinical Effectiveness & Safety
322 CCSVI Patients with MS undergoing venoplasty
13
MS SPECIFIC FUNCTIONAL COMPOSITE SCORING SYSTEM
National MS Society
14
MS SPECIFIC QUALITY OF LIFE QUESTIONAIRE
National MS Society
15
Magnetic Resonance Imaging
16
Assessment before treatment
& at 6 months Doppler Scan MRI Independent neurological examination scoring (MSFC) Quality of Life scoring
17
322 CCSVI Patients with Multiple Sclerosis
Results 322 CCSVI Patients with Multiple Sclerosis 99 % Technical Success
18
322 CCSVI Patients with Multiple Sclerosis
Results 322 CCSVI Patients with Multiple Sclerosis Complications : 1 transient atrial fibrillation 1 rash 2 extravasation of contrast
19
MSFC SCORE {Z arm average + Z leg average + Z cognitive}/3.0
Pre-treatment score Post treatment score A decrease or an increase in the MSFC score represents, respectively, deterioration or improvement in neurological functions.
20
MSQoL QoL Pre Rx(Physical) ± SD 43.06 ± 17.93
QoL Post Rx(Physical) ± SD ± 22.17 QoL Pre Rx(Mental) ± SD ± 24.01 QoL Post Rx(Mental) ± SD ± 21.57
21
NATIONAL INSTITUE FOR CLINICAL EXCELLENCE DRAFT GUIDELINES
22
Conclusions CCSVI is associated with Multiple Sclerosis
Endovascular treatment is feasible as day case Balloon angioplasty has limitations IVUS is helpful but not essential
23
Venoplasty Programme Donald Reid Khalid Irshad Raj Velu Martin Errington David Kean Barun Majumber Thomas Gilhooly David Pugh Fiona Hassel
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.